Anti-M üllerian Hormone Levels and Risk of Cancer in Women

Higher circulating anti-M üllerian hormone (AMH) levels in women have been associated with increased breast cancer risk[1]. Although AMH is primarily known for its functions in sexual differentiation during embryogenesis[2] and ovarian follicle development[3], histologic evidence on the expression of AMH receptor type 2 (AM HR2) in different non-gonadal tissues[4–6] suggests responsiveness of a wide range of tissues to AMH.

Source: Maturitas - October 31, 2020 Category: Primary Care Authors: Ren ée M.G. Verdiesen, Carla H. van Gils, Rebecca K. Stellato, W.M. Monique Verschuren, Frank J.M. Broekmans, Annelien C. de Kat, Yvonne T. van der Schouw, N. Charlotte Onland-Moret Source Type: research